Novo Nordisk to Test GLP-1 Drugs Against Addiction
Novo Nordisk, maker of Ozempic and Wegovy, says they will start testing GLP-1 drugs for use in treating addiction.
The Digital Revolution in Addiction Treatment, Part 2
The smartphone has revolutionized addiction treatment for substance use disorders and behavioral disorders.
The Digital Revolution in Addiction Treatment, Part 1
The smartphone is revolutionizing addiction treatment, starting with screening and referral.
The Profit Potential in the Opioid Epidemic
A journal for pharmaceutical investors takes a look at the profit potential in treating opioid use disorders.
Preventing Relapse During Recovery From Opioid Use Disorder
Researchers at the University of Maryland team up to study the genetics of relapse during recovery from opioid use disorder.
5NP Acupuncture in Addiction Treatment
5NP acupuncture provides a safe, inexpensive therapy for withdrawal symptoms from addiction treatment.